Holen Sie sich die Stockscreener-App
0.2252
3.97%
-0.0093
Handel nachbörslich:
.23
0.0048
+2.13%
Schlusskurs vom Vortag:
$0.2345
Offen:
$0.2275
24-Stunden-Volumen:
397.65K
Relative Volume:
0.20
Marktkapitalisierung:
$7.46M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-22.71M
KGV:
-0.0192
EPS:
-11.71
Netto-Cashflow:
$-18.24M
1W Leistung:
+2.36%
1M Leistung:
-18.67%
6M Leistung:
-52.19%
1J Leistung:
-73.51%
1-Tages-Spanne:
$0.217
$0.2335
1-Wochen-Bereich:
$0.209
$0.2425
52-Wochen-Spanne:
$0.2023
$3.97
Genprex Inc Stock (GNPX) Company Profile
Firmenname
Genprex Inc
Sektor
Branche
Telefon
512-537-7997
Adresse
1601 TRINITY STREET, BLDG. B, AUSTIN, TX
Vergleichen Sie GNPX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GNPX
Genprex Inc
|
0.2252 | 7.12M | 0 | -22.71M | -18.24M | -11.71 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 96.01B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 57.86B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 57.02B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.10B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.45B | 3.81B | -644.79M | -669.77M | -6.24 |
Genprex Inc Stock (GNPX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-01-26 | Eingeleitet | National Securities | Buy |
| 2019-04-29 | Eingeleitet | Noble Capital Markets | Outperform |
Genprex Inc Aktie (GNPX) Neueste Nachrichten
News impact scoring models applied to Genprex Inc.Earnings Miss & AI Driven Stock Price Forecasts - Newser
Has Genprex Inc. formed a bullish divergence2025 Historical Comparison & Fast Gain Stock Trading Tips - Newser
Is Genprex Inc. stock bottoming outTrade Volume Summary & Reliable Price Breakout Alerts - Newser
Predicting Genprex Inc. trend using moving averagesMarket Performance Summary & Fast Exit and Entry Strategy Plans - Newser
Applying chart zones and confluence areas to Genprex Inc.Quarterly Earnings Report & Expert Curated Trade Ideas - Newser
Detecting support and resistance levels for Genprex Inc.July 2025 Gainers & Free Real-Time Volume Trigger Notifications - Newser
How to build a custom watchlist for Genprex Inc.July 2025 Levels & Precise Buy Zone Identification - Newser
Using fundamentals and technicals on Genprex Inc.Free Weekly Top Gainers Forecast Watchlist - Newser
Genprex GNPX 2025Q2 Earnings Preview Downside Ahead on Challenging Revenue Landscape - AInvest
What makes Genprex Inc. stock price move sharplyShort Term Gain Strategy with AI Logic - Newser
Multi factor analysis applied to Genprex Inc.Free High Win Rate Trading Opportunities - Newser
Technical analysis overview for Genprex Inc. stockFree Swing Trading Entry Point Signals - Newser
Is this a good reentry point in Genprex Inc.Free Capital Efficiency Optimized Stock Alerts - Newser
Quant Strategy Flags Genprex Inc. for EntryCommunity Shared Smart Money Signals Show Movement - beatles.ru
Is Genprex Inc. stock a top performer YTDBest Stocks for Rapid Income - thegnnews.com
Genprex GNPX 2025Q2 Earnings Preview Upside Ahead on Diabetes Gene Therapy Advancements - AInvest
Genprex Issues Stockholder Letter and Provides 2025 Corporate Update - The Malaysian Reserve
Genprex Issues Stockholder Letter And Provides 2025 Corporate Update - TradingView
Genprex Announces Stockholder Letter and Corporate Update - TipRanks
Genprex Achieves Major Clinical Milestones: CEO Reveals Ambitious Plans for Cancer and Diabetes Gene Therapies - Stock Titan
Genprex Inc. Rebounds From Oversold Zone — Now WhatPattern Alert With ROI Driven Strategy Shared - metal.it
How strong is Genprex Inc. company’s balance sheetOverwhelming profit margins - Jammu Links News
Is it the right time to buy Genprex Inc. stockBuild a winning investment strategy today - Jammu Links News
Should I hold or sell Genprex Inc. stock in 2025Discover high-impact investment opportunities - Jammu Links News
How many analysts rate Genprex Inc. as a “Buy”Get high-impact stock recommendations now - Jammu Links News
What catalysts could drive Genprex Inc. stock higher in 2025Free Stock Market Query - Jammu Links News
How volatile is Genprex Inc. stock compared to the marketBuild a portfolio for long-term financial success - Jammu Links News
Is Genprex Inc. stock overvalued or undervaluedExceptional risk-adjusted gains - Jammu Links News
What are the latest earnings results for Genprex Inc.Invest confidently with professional guidance - Jammu Links News
When is Genprex Inc. stock expected to show significant growthAchieve consistent high returns with low risk - Jammu Links News
What is the dividend policy of Genprex Inc. stockUnlock exclusive trading strategies for gains - Jammu Links News
What institutional investors are buying Genprex Inc. stockExpert guidance for superior capital growth - Jammu Links News
Is Genprex Inc. a growth stock or a value stockBuild a diversified portfolio for risk mitigation - Jammu Links News
Price action breakdown for Genprex Inc.Weekly Return Plan for Conservative Traders - Newser
Will Genprex Inc. stock benefit from interest rate changesFree Daily Volume Spike Trading Signals - Newser
Relative strength of Genprex Inc. in sector analysisROI Focused Watchlist with Trade Confidence - Newser
Genprex (GNPX) to Release Quarterly Earnings on Friday - Defense World
Is Genprex Inc. stock reversal real or fakeFree Entry Zone Strategy for Consistent Profit - Newser
Finanzdaten der Genprex Inc-Aktie (GNPX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):